Abstract Details
10/09/2023 | 10:00 AM - 11:00 AM | Courtroom
Hearing and Vestibular Monitoring Protocol for Infants and Children with Congenital Cytomegalovirus
Abstract Summary
Children with congenital Cytomegalovirus (cCMV) are at risk for both hearing loss and vestibular dysfunction. The impacts of hearing loss on speech and language development are widely understood (Moeller et al., 2007), however the impacts of vestibular dysfunction are often overlooked. Studies are beginning to investigate the developmental consequences of vestibular disorders in children, and are finding deficits in visuospatial tasks, executive functions, and spatial awareness, which can impact reading/academics, social skills, and memory (Hazen & Cushing, 2021). Research has also demonstrated vestibular dysfunction with highly variable presentations, occurring independent of hearing status in each ear. Kokkola et al (2023) found a higher incidence of vestibular dysfunction, 19%, than hearing loss, 10%, in a cohort of 6 to 7-year-old children with cCMV. A systematic review of current literature that included a broader vestibular test battery found between 45-90% prevalence of vestibular dysfunction in children with cCMV, demonstrating the need for a comprehensive test battery to assess different parts of the vestibular system (Shears et al., 2021). At Children’s Hospital Colorado (CHCO), the audiology team has developed an evidence-based hearing and vestibular monitoring protocol for infants diagnosed with cCMV. The vestibular monitoring protocol includes developmentally appropriate balance screens starting at 15 months of age, as well as recommendations for when formal vestibular testing should be pursued. This protocol is a helpful tool for audiologists, early intervention specialists, therapists, and parents who want to screen for balance disorders. Data from patients with cCMV evaluated in the CHCO vestibular lab show varying abnormalities as the literature suggests. Tests and modification strategies will be shared, as evaluating infants and young children pose unique challenges. Discussion will also focus on treatment recommendations when infants/children are diagnosed with vestibular dysfunction.
Learning Objectives
- Participants will be able to describe the risk of vestibular dysfunction for infants and children with congenital cytomegalovirus (cCMV).
- Participants will be able to perform a screen for vestibular dysfunction and know when to recommend vestibular testing.
- Participants will be able to identify vestibular tests and modifications used with infants and young children of different ages and developmental levels.
Presentation
3440589_16049KarenHendrick.pdf
Handouts
Presenters
Karen Hendrick | Primary Presenter
karen.hendrick@childrenscolorado.org;
Dr. Karen Hendrick is a clinical audiologist and Vestibular Clinical Practice Specialist at Children’s Hospital Colorado. She graduated with her AuD from the University of Washington in 2015, following an externship at Seattle Children’s Hospital. She served on the board of the Colorado Academy of Audiology as the Vice President of Education from 2018 to 2020. In addition to pediatric vestibular testing, Dr. Hendrick is also passionate about global health. She has volunteered with Healing the Children to help establish rural pediatric clinics throughout Guatemala and with the Global Foundation for Children with Hearing Loss to provide diagnostic training in Mongolia and equipment support in Bhutan.
ASHA DISCLOSURE
Financial - No relevant financial relationship exists.
Nonfinancial - No relevant nonfinancial relationship exists.
AAA DISCLOSURE
Financial - Receives support from Children's Hospital Colorado (CHCO) for Employed by CHCO. .
Elissa Jodon | Co-Presenter
elissa.jodon@childrenscolorado.org;
Dr. Elissa Jodon is a clinical audiologist at Children’s Hospital Colorado. She graduated with her Doctorate of Audiology (Au.D.) from the University of Texas at Austin in 2016 and completed her externship at Texas Children’s Hospital in Houston, Texas. She has served on the board of the Colorado Academy of Audiology as Vice President of Professional Issues from 2020-2021. At Children’s Hospital Colorado, Dr. Jodon is a member of the vestibular and inpatient teams, as well as the consulting audiologist for the 22q Deletion and Metabolic Disorders multi-disciplinary clinics. She has also contributed to the Children’s Hospital Colorado clinical practice guideline for Audiology Management of Congenital Cytomegalovirus. Dr. Jodon is passionate about pediatric audiology diagnostics and quality improvement.
ASHA DISCLOSURE
Financial - No relevant financial relationship exists.
Nonfinancial - No relevant nonfinancial relationship exists.
AAA DISCLOSURE
Financial - Receives support from employed by Children's Hospital Colorado for .